X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
unprovoked anaphylaxis (10) 10
humans (9) 9
index medicus (9) 9
immunology (7) 7
systemic mastocytosis (7) 7
allergy (6) 6
antibodies, anti-idiotypic - therapeutic use (5) 5
antibodies, monoclonal, humanized - therapeutic use (5) 5
omalizumab (5) 5
allergy and immunology (4) 4
anti-allergic agents - therapeutic use (4) 4
immunotherapy (4) 4
venom immunotherapy (4) 4
anti-ige (3) 3
internal medicine (3) 3
male (3) 3
mast cells - pathology (3) 3
mastocytosis (3) 3
acute myeloid-leukemia (2) 2
adult (2) 2
aged (2) 2
allergens (2) 2
american-academy (2) 2
anaphylaxis (2) 2
anaphylaxis - etiology (2) 2
anaphylaxis - immunology (2) 2
animals (2) 2
antibodies (2) 2
asthma (2) 2
c-kit mutation (2) 2
care and treatment (2) 2
desensitization, immunologic (2) 2
diagnostic-criteria (2) 2
fc-epsilon-ri (2) 2
female (2) 2
hematology (2) 2
ige (2) 2
immunoglobulin e (2) 2
immunoglobulin e - immunology (2) 2
immunology/american-college (2) 2
indolent systemic mastocytosis (2) 2
kit (2) 2
mast cells - drug effects (2) 2
mast cells - immunology (2) 2
mastocytosis - drug therapy (2) 2
mastocytosis - immunology (2) 2
mastocytosis - pathology (2) 2
medicine, general & internal (2) 2
monoclonal antibodies (2) 2
mortality (2) 2
patients (2) 2
prognosis (2) 2
protein kinase inhibitors - therapeutic use (2) 2
recurrence (2) 2
risk factors (2) 2
tyrosine kinase inhibitor (2) 2
venom (2) 2
1-alkyl-2-acetylglycerophosphocholine esterase - genetics (1) 1
1-alkyl-2-acetylglycerophosphocholine esterase - immunology (1) 1
1st unprovoked seizure (1) 1
1st-seizure (1) 1
abridged index medicus (1) 1
ace (1) 1
acute coronary syndromes (1) 1
acute symptomatic seizure (1) 1
aged, 80 and over (1) 1
allergic reactions (1) 1
allergic rhinitis (1) 1
allergies (1) 1
allergology (1) 1
analysis (1) 1
anaphylaxis - drug therapy (1) 1
anaphylaxis - pathology (1) 1
anaphylaxis - prevention & control (1) 1
anaphylaxis - therapy (1) 1
anti-ige therapy (1) 1
antibodies, anti-idiotypic - adverse effects (1) 1
antibodies, anti-idiotypic - pharmacology (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - pharmacology (1) 1
antibody-targetable cell surface membrane proteins (1) 1
antihistamine (1) 1
antimediator therapy (1) 1
aortic-aneurysm formation (1) 1
bees (1) 1
biochemistry & molecular biology (1) 1
biology (1) 1
biopsy (1) 1
bone and bones - drug effects (1) 1
bone and bones - immunology (1) 1
bone and bones - pathology (1) 1
bone marrow (1) 1
brentuximab vedotin (1) 1
cardiac patients (1) 1
cardiovascular disease (1) 1
cardiovascular diseases - complications (1) 1
cardiovascular diseases - diagnostic imaging (1) 1
cardiovascular diseases - pathology (1) 1
cardiovascular diseases - physiopathology (1) 1
case reports (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunology and Allergy Clinics of North America, ISSN 0889-8561, 2014, Volume 34, Issue 2, pp. 433 - 447
Treatment recommendations for mastocytosis are based mostly on expert opinion rather than evidence obtained from controlled clinical trials. In this article,... 
Mediator-related symptoms | Mastocytosis | Antimediator therapy | Antihistamine | Anti-IgE | Platelet-activating factor | TRYPTASE LEVELS | INDUCED ANAPHYLAXIS | MAST-CELLS | IMMUNOLOGY | VENOM IMMUNOTHERAPY | UNPROVOKED ANAPHYLAXIS | MEDIATOR RELEASE | ALLERGY | DISODIUM-CROMOGLYCATE | INDOLENT SYSTEMIC MASTOCYTOSIS | PLACEBO-CONTROLLED TRIAL | CUTANEOUS-MASTOCYTOSIS | Bone and Bones - pathology | Humans | Central Nervous System - pathology | Omalizumab | Histamine Antagonists - therapeutic use | Mastocytosis - immunology | Proto-Oncogene Proteins c-kit - immunology | Thiazoles - therapeutic use | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | 1-Alkyl-2-acetylglycerophosphocholine Esterase - immunology | Central Nervous System - immunology | Gastrointestinal Tract - pathology | Mastocytosis - genetics | Bone and Bones - drug effects | Gastrointestinal Tract - immunology | 1-Alkyl-2-acetylglycerophosphocholine Esterase - genetics | Proto-Oncogene Proteins c-kit - genetics | Antibodies, Anti-Idiotypic - therapeutic use | Skin - pathology | Skin - immunology | Dasatinib | Mast Cells - immunology | Gene Expression | Antibodies, Monoclonal, Humanized - therapeutic use | Mastocytosis - drug therapy | Gastrointestinal Tract - drug effects | Mastocytosis - pathology | Mast Cells - drug effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Mast Cells - pathology | Central Nervous System - drug effects | Bone and Bones - immunology | Skin - drug effects
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 01/2019, Volume 20, Issue 3, p. 552
Journal Article
FRONTIERS IN MEDICINE, ISSN 2296-858X, 07/2017, Volume 4, p. 110
Mastocytosis refers to a heterogeneous group of disorders resulting from the clonal proliferation of abnormal mast cells and their accumulation in the skin... 
C-KIT MUTATION | mast cell | ACUTE MYELOID-LEUKEMIA | KINASE INHIBITOR | systemic mastocytosis | UNPROVOKED ANAPHYLAXIS | targeted treatment | PEDIATRIC MASTOCYTOSIS | DASATINIB BMS-354825 | MEDICINE, GENERAL & INTERNAL | CUTANEOUS MASTOCYTOSIS | KIT | tyrosine kinase inhibitor | INDOLENT SYSTEMIC MASTOCYTOSIS | HUMAN MAST-CELLS | DIAGNOSTIC-CRITERIA
Journal Article
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.